US Bancorp DE lowered its stake in shares of MAXIMUS, Inc. (NYSE:MMS) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,219 shares of the health services provider’s stock after selling 2,123 shares during the period. US Bancorp DE owned 0.06% of MAXIMUS worth $3,022,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the business. Public Employees Retirement System of Ohio lifted its holdings in MAXIMUS by 0.3% during the second quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock worth $4,588,000 after buying an additional 207 shares during the period. Stifel Financial Corp lifted its holdings in MAXIMUS by 5.2% during the second quarter. Stifel Financial Corp now owns 9,186 shares of the health services provider’s stock worth $576,000 after buying an additional 455 shares during the period. Cubist Systematic Strategies LLC lifted its holdings in MAXIMUS by 16.0% during the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after buying an additional 546 shares during the period. Eqis Capital Management Inc. lifted its holdings in MAXIMUS by 13.7% during the third quarter. Eqis Capital Management Inc. now owns 6,663 shares of the health services provider’s stock worth $430,000 after buying an additional 804 shares during the period. Finally, Pacer Advisors Inc. lifted its holdings in MAXIMUS by 11.5% during the third quarter. Pacer Advisors Inc. now owns 9,688 shares of the health services provider’s stock worth $625,000 after buying an additional 1,000 shares during the period. Institutional investors own 95.55% of the company’s stock.
A number of analysts have weighed in on the company. Canaccord Genuity restated a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. Zacks Investment Research lowered MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. Finally, Maxim Group restated a “hold” rating and set a $69.00 target price (up previously from $66.00) on shares of MAXIMUS in a report on Thursday, February 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $66.60.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.01. The business had revenue of $623.10 million for the quarter, compared to the consensus estimate of $624.36 million. MAXIMUS had a return on equity of 22.93% and a net margin of 8.99%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.71 earnings per share. equities research analysts anticipate that MAXIMUS, Inc. will post 3.44 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s payout ratio is presently 5.36%.
In other news, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $71.73, for a total transaction of $71,730.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, General Counsel David Francis sold 1,373 shares of the company’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $65.35, for a total value of $89,725.55. Following the transaction, the general counsel now directly owns 13,617 shares in the company, valued at $889,870.95. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 69,617 shares of company stock worth $4,789,052. Insiders own 2.48% of the company’s stock.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.